It is interesting that free doxorubicin diffused into both the CD19-positive lymphoma cells and the CD19-negative control cells (Figure 7 upper panel), while Apt-Dox mainly entered the CD19-positive cells (Figure 7 lower panel). This evidence concerns the gene CD19 and lymphoma.